GlassScriptPhysician profile
Ahmed Hashim
NPI 1841258266
$6,064.96
in general payments reported to CMS, 2019-2025
45 companies · $921 in 2025
The $921 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $506 · 2020: $639 · 2021: $914 · 2022: $547 · 2023: $1,242 · 2024: $1,297 · 2025: $921.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,360 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,359.83 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $794.67 | 2019-2024 | Xarelto, Opsumit |
| Pfizer INC. | $439.47 | 2019-2025 | |
| Amgen INC. | $417.69 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $417.36 | 2019-2025 | General - Balloon Catheters, Rotapro |
| Merck Sharp & Dohme LLC | $408.70 | 2021-2025 | Verquvo, Winrevair |
| Novartis Pharmaceuticals Corporation | $371.23 | 2019-2025 | |
| Abiomed | $360.35 | 2020-2023 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $315.44 | 2020-2024 | Jardiance |
| Esperion Therapeutics, INC. | $301.29 | 2020-2025 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $288.55 | 2019-2025 | Farxiga, Wainua |
| E.R. Squibb & Sons, L.L.C. | $241.73 | 2019-2025 | Camzyos |
| Abbott Laboratories | $238.94 | 2020-2025 | Cardiomems |
| Scpharmaceuticals INC. | $139.23 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $113.17 | 2019-2024 | Evkeeza, Praluent |
| Astellas Pharma US INC | $111.62 | 2019-2023 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $94.57 | 2019-2025 | Onpattro |
| Inari Medical, INC. | $83.98 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $78.15 | 2020-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $63.99 | 2022-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Bayer Healthcare Pharmaceuticals INC. | $61.94 | 2025 | |
| Medtronic, INC. | $59.42 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $45.82 | 2019-2021 | |
| Baxter Healthcare | $45.64 | 2024 | Biopharma Sol - Contract Manuf |
| Novo Nordisk INC | $43.48 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Philips North America LLC | $42.50 | 2023 | |
| Azurity Pharmaceuticals, INC. | $41.87 | 2023-2024 | Edarbi, Edarbi |
| Kiniksa Pharmaceuticals International, Plc | $39.98 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $36.49 | 2023 | Inpefa |
| Glaxosmithkline, LLC. | $34.01 | 2025 | Shingrix, Arexvy |
| Impulse Dynamics (USA) INC. | $32.19 | 2023 | Optimizer |
| Daiichi Sankyo INC. | $29.52 | 2023 | Injectafer |
| Recor Medical INC | $26.29 | 2025 | Paradise Ultrasound Renal Denervation System |
| Medical Device Business Services, INC. | $24.00 | 2025 | Vistaseal |
| Biotronik INC. | $22.98 | 2024 | Biomonitor |
| Inspire Medical Systems, INC. | $21.77 | 2025 | Inspire |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $21.58 | 2019 | |
| Heartflow, INC. | $20.49 | 2025 | |
| Csl Behring | $20.07 | 2019 | |
| Medicomp INC | $19.47 | 2023 | Telepatch Cardiac Monitor |
| Kiniksa Pharmaceuticals, LTD. | $19.45 | 2023 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $19.09 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $16.34 | 2025 | Opsumit |
| Irhythm Technologies, INC. | $15.96 | 2023 | Zio Xt Patch |
| United Therapeutics Corporation | $13.32 | 2023 | Orenitram |
| Itamar Medical INC | $11.16 | 2023 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Hashim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.